List of Clobex drug patents
Clobex is owned by Galderma Labs.
Clobex contains Clobetasol Propionate.
Clobex has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Clobex are:
- US7700081
Clobex was authorised for market use on 05 February, 2004.
Clobex is available in shampoo;topical dosage forms.
Clobex can be used as topical treatment of scalp psoriasis.
The generics of Clobex are possible to be released after 03 January, 2022.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7700081 | GALDERMA LABS | Foaming compositions for hair care |
Jan, 2022
(1 year, 2 months ago) | |
Drugs and Companies using CLOBETASOL PROPIONATE ingredient
Market Authorisation Date: 05 February, 2004
Treatment: Topical treatment of scalp psoriasis
Dosage: SHAMPOO;TOPICAL
CLOBEX family patents
4
United States
2
Germany
2
Austria
2
France
2
Japan
2
European Union
1
Russia
1
Spain
1
Brazil
1
New Zealand
1
Norway
1
Argentina
1
China
1
Korea, Republic of
1
Hong Kong
1
South Africa
1
Canada
1
Hungary
1
Poland
1
Australia
1
Denmark
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic